Redux Electrolyte Creme — Class II medical device recall Z-1604-2024
Ongoing recall by Parker Laboratories, Inc., reported 2024-05-01, distributed nationwide. Product demonstrates low viscosity.
| Recall number | Z-1604-2024 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Parker Laboratories, Inc., Fairfield, NJ, United States |
| Recall initiated | 2024-03-22 |
| Classified | 2024-04-19 |
| Reported by FDA | 2024-05-01 |
| Distributed | Nationwide (US) |
| UPC / GTIN / UDI-DI | 00855683006395, 10855683006392, 20855683006399 |
| Lot numbers | A0523002, A1122010 |
| Model numbers | 66-04 |
Product
Redux Electrolyte Creme, Product Ref. 66-04. Highly conductive electrolyte creme.
Reason for recall
Product demonstrates low viscosity.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1604-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.